Abstract P094: Gender Difference of Left Ventricular Geometry and Prolonged QRS Duration on Electrocardiogram: MESA (Multi-Ethnic Study of Atherosclerosis)

Circulation ◽  
2015 ◽  
Vol 131 (suppl_1) ◽  
Author(s):  
Yuko Inoue ◽  
Hiroshi Ashikaga ◽  
Yoshiaki Ohyama ◽  
Gustavo Volpe ◽  
Bharath Ambale-Venkatesh ◽  
...  

Backgrounds: Prolonged QRS duration (QRSd) on electrocardiogram (ECG) is commonly found in otherwise healthy individuals. However, geometrical factors of the ventricles that determine QRSd are poorly defined. T1 time by cardiovascular magnetic resonance (CMR) is good parameter to estimate extracellular expansion (ECE). Our objective was to evaluate the relationship between QRSd and CMR measures of tissue composition in a large community-based multiethnic population. Methods: A total of 1,615 participants (52% women; age range 44 to 84 years) of the MESA cohort were evaluated with T1 mapping by using 1.5-T CMR scanners. We excluded the participants with focal scar on delayed enhancement CMR and bundle branch block. Midventricular short-axis T1 maps were acquired before and at 12- and 25-min after administration of gadolinium contrast using Modified Look-Locker Inversion Recovery sequence. Results: Longer QRSd was associated with greater LV end diastolic volume (LVEDV) index (p <0.001), LV mass index (p <0.001), and stroke volume index (p <0.01) in both women and men. In addition, longer QRSd was associated with lower ejection fraction (p<0.001), circumferential shortening (p = 0.04), torsion (p <0.001), and longer post-contrast T1 times at 12 min indicating less ECE (p = 0.001) in women only. Longer T1 time remained significant after adjusting for LVEDV, LV mass and QRS voltage. Conclusions: In a large multiethnic population, longer QRSd was associated with lower ECE and LV dysfunction in women. However, these relationships were sex dependent and were absent in men.

1998 ◽  
Vol 85 (4) ◽  
pp. 1368-1375 ◽  
Author(s):  
R. L. Stepien ◽  
K. W. Hinchcliff ◽  
P. D. Constable ◽  
J. Olson

The cardiac morphology of 77 conscious Alaskan sled dogs before and after 5 mo of endurance training (20 km/day team pulling a sled and musher) was studied using two-dimensional and M-mode echocardiography. Subgroups included dogs with at least one season of previous training (“veterans”) and dogs undergoing their first season of training (“rookies”). Training resulted in a significant ( P< 0.05) decrease in resting heart rate (−15%) and significant increases in interventricular septal thickness (systole, 15%; diastole, 13%), left ventricular (LV) internal dimension in diastole (LVIDd, 4%), LV free wall thickness in systole (9%) and diastole (LVWd, 9%), and left atrial diameter (5%) in all dogs, but the increase in LVWd was greater in rookies (16%) than in veterans (7%). Training increased end-diastolic volume index (8%), LV mass index (24%), and heart weight index (24%) and decreased the LVIDd-to-LVWd ratio (−6%) but did not alter cardiac index. We conclude that increased LV mass attributable to LV dilation and hypertrophy is associated with endurance training in Alaskan sled dogs. Disproportionate LV wall thickening accompanying LV dilation suggests that cardiac morphological changes are due to volume and pressure loading. These training-induced changes are similar to those documented in human athletes undergoing combined isometric and isotonic training and differ from studies of dogs trained on treadmills.


Author(s):  
Laura Banks ◽  
Saif Al-Mousawy ◽  
Mustafa A Altaha ◽  
Kaja Koneiczny ◽  
Wesseem Osman ◽  
...  

Background: The relationship between structural and electrical remodeling in the heart, particularly after long-standing endurance training, remains unclear. Signal-averaged electrocardiogram (SAECG) may provide a more sensitive method to evaluate cardiac remodeling than a 12-lead electrocardiogram (ECG). Accurate measures of electrical function (SAECG filtered QRS duration (fQRSd) and late potentials (LP) and left-ventricular mass (cardiac magnetic resonance, CMR) can allow an assessment of structural and electrical remodeling. Methods: Endurance athletes (45-65 years old, >10 years of endurance sport), screened to exclude cardiac disease, had standardized 12-lead ECG, SAECG, resting echocardiogram (ECHO), and CMR performed. SAECG fQRSd was correlated with QRS duration on the 12-lead ECG, and ECHO and CMR-derived left ventricular (LV) mass. Results: Participants (n=82, 67% male, mean age: 54±6 years, mean VO2max: 50±7 ml/kg/min) had a CMR-derived LV mass of 118±28 g/m2 and a fQRSd of 112±8 ms (46% had abnormal fQRSd (>114 msec), and 51% met clinical threshold for abnormal SAECG). fQRSd was positively correlated with the 12-lead ECG QRS duration (r=0.83), ECHO-derived LV mass (r=0.60), CMR-derived LV mass (r=0.58) and LV end-diastolic volume (r=0.63, p<0.001 for all). fQRSd had higher correlations with ECHO and CMR-derived LV mass than 12-lead ECG (p<0.0008 and p<0.0005, respectively). Conclusion: In a healthy cohort of middle-aged endurance athletes, the SAECG is often abnormal by conventional criteria, and is correlated with structural remodeling, but CMR evaluation does not indicate pathologic structural remodeling. SAECG fQRSd is superior to the 12-lead ECG for the electrocardiographic evaluation of LV mass.


1987 ◽  
Vol 62 (1) ◽  
pp. 278-283 ◽  
Author(s):  
M. W. Bungo ◽  
D. J. Goldwater ◽  
R. L. Popp ◽  
H. Sandler

Echocardiographic measurements were obtained before and after space flight from 17 members of four shuttle crews. Measurements obtained 1 h after landing (L+0) compared with preflight values (n = 7) demonstrated an increase in heart rate (HR) (16 beats/min, 30.5%, P less than 0.05), mean arterial pressure (12%, P less than 0.05), and systemic vascular resistance (34%, P less than 0.05). End-diastolic volume index (EDVI) fell 17 ml/m2 (-23%, P less than 0.005) and stroke volume index (SVI) fell 15 ml/m2 (-28%, P less than 0.05). Repeat measurements taken 1–2 wk later (n = 17) demonstrated that HR had returned to normal (4 beats/min, P less than 0.05); however, EDVI remained significantly below preflight levels (-11%, P less than 0.005). End-systolic volume index (ESVI) was also still significantly lower (-23%, P less than 0.01). This delayed recovery occurred despite ability of the subjects to fully ambulate and exercise during the postflight period. These results indicate that spaceflight induces significant changes in heart volume affecting left ventricular function. The exact reasons for these specific changes remain unknown and will require additional measurements before, during, and after flight. The prolonged recovery period for the present subject group probably relates to their high level of aerobic conditioning.


2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Alexandra Doronina ◽  
István Ferenc Édes ◽  
Adrienn Ujvári ◽  
Zoltán Kántor ◽  
Bálint Károly Lakatos ◽  
...  

We aimed to characterize female athlete’s heart in elite competitors in the International Federation of Bodybuilding and Fitness (IFBB) Bikini Fitness category and compare them to athletes of a more dynamic sport discipline and healthy, sedentary volunteers using 3D echocardiography. Fifteen elite female fitness athletes were recruited and compared to 15 elite, age-matched female water polo athletes and 15 age-matched healthy, nontrained controls. Using 3D echocardiography, left ventricular (LV) and right ventricular (RV) end-diastolic volume index (EDVi) and LV mass index (LVMi) were measured. Fitness athletes presented similar LV and RV EDVi compared to healthy, sedentary volunteers. Water polo athletes, however, had higher LV and also RV EDVi (fitness versus water polo versus control; LVEDVi: 76±13 versus 84±8 versus 73±8 ml/m2, ANOVA p=0.045; RVEDVi: 61±12 versus 86±14 versus 55±9 ml/m2, p<0.0001). LVMi was significantly higher in the athlete groups; the hypertrophy, however, was even more prominent in water polo athletes (78±13 versus 91±10 versus 57±10 g/m2, p<0.0001). To the best of our knowledge, this is the first study to characterize female athlete’s heart of IFBB Bikini Fitness competitors. The predominantly static exercise regime induced a mild, concentric-type LV hypertrophy, while in water polo athletes higher ventricular volumes and eccentric LV hypertrophy developed.


2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Matthias Rau ◽  
Kirsten Thiele ◽  
Niels-Ulrik Korbinian Hartmann ◽  
Alexander Schuh ◽  
Ertunc Altiok ◽  
...  

Abstract Background In the EMPA-REG OUTCOME trial (Empagliflozin Cardiovascular Outcome Event Trial) treatment with the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin significantly reduced heart failure hospitalization (HHF) in patients with type 2 diabetes mellitus (T2D) and established cardiovascular disease. The early separation of the HHF event curves within the first 3 months of the trial suggest that immediate hemodynamic effects may play a role. However, hitherto no data exist on early effects of SGLT2 inhibitors on hemodynamic parameters and cardiac function. Thus, this study examined early and delayed effects of empagliflozin treatment on hemodynamic parameters including systemic vascular resistance index, cardiac index, and stroke volume index, as well as echocardiographic measures of cardiac function. Methods In this placebo-controlled, randomized, double blind, exploratory study patients with T2D were randomized to empagliflozin 10 mg or placebo for a period of 3 months. Hemodynamic and echocardiographic parameters were assessed after 1 day, 3 days and 3 months of treatment. Results Baseline characteristics were not different in the empagliflozin (n = 22) and placebo (n = 20) group. Empagliflozin led to a significant increase in urinary glucose excretion (baseline: 7.3 ± 22.7 g/24 h; day 1: 48.4 ± 34.7 g/24 h; p < 0.001) as well as urinary volume (1740 ± 601 mL/24 h to 2112 ± 837 mL/24 h; p = 0.011) already after one day compared to placebo. Treatment with empagliflozin had no effect on the primary endpoint of systemic vascular resistance index, nor on cardiac index, stroke volume index or pulse rate at any time point. In addition, echocardiography showed no difference in left ventricular systolic function as assessed by left ventricular ejections fraction and strain analysis. However, empagliflozin significantly improved left ventricular filling pressure as assessed by a reduction of early mitral inflow velocity relative to early diastolic left ventricular relaxation (E/eʹ) which became significant at day 1 of treatment (baseline: 9.2 ± 2.6; day 1: 8.5 ± 2.2; p = 0.005) and remained apparent throughout the study. This was primarily attributable to reduced early mitral inflow velocity E (baseline: 0.8 ± 0.2 m/s; day 1: 0.73 ± 0.2 m/sec; p = 0.003). Conclusions Empagliflozin treatment of patients with T2D has no significant effect on hemodynamic parameters after 1 or 3 days, nor after 3 months, but leads to rapid and sustained significant improvement of diastolic function. Trial registration EudraCT Number: 2016-000172-19; date of registration: 2017-02-20 (clinicaltrialregister.eu)


Sign in / Sign up

Export Citation Format

Share Document